Transient improvement of severe and rapidly progressive dysphagia with autologous peripheral blood haematopoietic stem cell transplantation in a patient with long standing dermatomyositis refractory to standard therapy

被引：0
|
作者：
Milanetti, F. [1 ]
Porrini, R. [1 ]
Marini, F. [1 ]
Nisini, R. [2 ]
Conte, E. [1 ]
Ferrari, A. [1 ]
Lagana, B. [1 ]
Montefusco, E. [1 ]
D'Amelio, R. [1 ]
机构：
[1] Univ Rome, Rome, Italy
[2] Ist Super Sanita, I-00161 Rome, Italy
来源：
BONE MARROW TRANSPLANTATION | 2013年 / 48卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S338 / S339
页数：2
相关论文
共 50 条
  • [41] Reduction in subfoveal choroidal thickness and peripapillary retinal thickness after high-dose melphalan therapy followed by autologous peripheral blood stem cell transplantation in a patient with POEMS syndrome
    Hirotaka, Y.
    Toshiyuki, O.
    Takayuki, B.
    Shuichi, Y.
    [J]. ACTA OPHTHALMOLOGICA, 2017, 95
  • [42] Long-term follow-up of highly selected autologous stem cell transplantation in severe rheumatoid arthritis with studies of peripheral blood reconstitution and macroscopic and histological arthroscopic appearances.
    Bingham, S
    Veale, D
    Fearon, U
    Reece, R
    Isaacs, J
    McGonagle, D
    Snowden, J
    Morgan, G
    Emery, P
    [J]. ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S290 - S290
  • [43] Successful management with urgent haploidentical-peripheral blood stem cell transplantation for a patient with severe aplastic anaemia who developed disseminated fungal infection following immunosuppressive therapy
    Ikenobe, Norihito
    Fujimori, Kentaro
    Gocho, Yoshihiro
    Myojin, Shota
    Yamada, Masaki
    Imadome, Kenichi
    Miyasaka, Mikiko
    Miyazaki, Osamu
    Yoneda, Akihiro
    Matsumoto, Shotaro
    Nakagawa, Satoshi
    Deguchi, Takao
    Iguchi, Akihiro
    Tomizawa, Daisuke
    Ogimi, Chikara
    Matsumoto, Kimikazu
    Sakaguchi, Hirotoshi
    [J]. EJHAEM, 2024,
  • [44] High-dose melphalane and autologous peripheral blood stem cell transplantation as a salvage therapy for diffuse large B-cell lymphoma refractory to 2nd or 3rd line treatment
    Kaddu-Mulindwa, D.
    Held, G.
    Pfreundschuh, M.
    Bittenbring, J.
    [J]. BONE MARROW TRANSPLANTATION, 2017, 52 : S446 - S446
  • [45] High-dose melphalane and autologous peripheral blood stem cell transplantation as a salvage therapy for diffuse large B-cell lymphoma refractory to 2nd or 3rd line treatment
    Bittenbring, J. T.
    Kaddu-Mulindwa, D.
    Held, G.
    Pfreundschuh, M.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 70 - 70
  • [46] Ann Arbor stage is the most important predictor of survival for refractory and relapsed HIV-associated lymphoma enrolled in a program of high dose therapy and autologous peripheral blood stem cell transplantation.
    Re, A
    Cattaneo, C
    Michieli, MG
    Casari, S
    Spina, M
    Rupolo, M
    Allione, B
    Ferremi, P
    Lanfranchi, A
    Mazzuccato, M
    Carosi, G
    Tirelli, U
    Rossi, G
    [J]. BLOOD, 2004, 104 (11) : 255A - 255A
  • [47] Long-term remission in a patient with refractory hepatosplenic gamma-delta T-cell lymphoma treated with bortezomib and high-dose CHOP-like chemotherapy followed by autologous peripheral stem cell transplantation
    Otrock, Z.
    Hatoum, H.
    Salem, Z.
    Tawil, A.
    Zaatari, G.
    Bazarbachi, A.
    [J]. BONE MARROW TRANSPLANTATION, 2007, 39 : S151 - S151
  • [48] Bone formation following lenalidomide-dexamethasone combination therapy in cases of multiple myeloma refractory to high-dose chemotherapy with bortezomib and autologous peripheral blood stem cell transplantation: report of a case and review of the literature
    Sekiguchi, Yasunobu
    Ichikawa, Kunimoto
    Wakabayashi, Mutsumi
    Sugimoto, Keiji
    Tomita, Shigeki
    Izumi, Hiroshi
    Nakamura, Noriko
    Sawada, Tomohiro
    Ohta, Yasunori
    Komatsu, Norio
    Noguchi, Masaaki
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (08): : 9609 - 9619
  • [49] MEL 100 followed by maintenance therapy with low-dose IL-2 as salvage treatment in multiple myeloma (MM) patients relapsed after standard autologous peripheral blood stem cell transplantation (AuPBSCT).
    Musto, P
    Falcone, A
    Bodenizza, C
    Sanpaolo, G
    Carella, AM
    [J]. BLOOD, 2001, 98 (11) : 395B - 395B
  • [50] Sustained major molecular response in the absence of any antileukaemic therapy after dasatinib treatment and autologous peripheral blood stem cell transplantation in a patient with imatinib-resistant myeloblastic-phase chronic myeloid leukaemia
    Rea, D.
    Raffoux, E.
    Cayuela, J-M
    Maarek, O.
    Dombret, H.
    [J]. LEUKEMIA, 2009, 23 (06) : 1158 - 1159
12345